EcoDrugPlus

Histone Deacetylase 11

Ensembl ID : ENSCDRG00005004608
Gene Symbol: HDAC11
3 Cross references
198 Possible Orthologues:

Histone Deacetylase 2

Ensembl ID : ENSCDRG00005003171
Gene Symbol: HDAC2
1 Cross references
204 Possible Orthologues:

Histone Deacetylase 3

Ensembl ID : ENSCDRG00005009144
Gene Symbol: HDAC3
3 Cross references
156 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSCDRG00005016731
Gene Symbol: HDAC4
1 Cross references
263 Possible Orthologues:

Histone Deacetylase 5

Ensembl ID : ENSCDRG00005013881
Gene Symbol: HDAC5
1 Cross references
194 Possible Orthologues:

Histone Deacetylase 6

Ensembl ID : ENSCDRG00005017433
Gene Symbol: HDAC6
1 Cross references
183 Possible Orthologues:

Histone Deacetylase 7

Ensembl ID : ENSCDRG00005012006
Gene Symbol: HDAC7
1 Cross references
263 Possible Orthologues:

Histone Deacetylase 8

Ensembl ID : ENSCDRG00005010238
Gene Symbol: HDAC8
1 Cross references
204 Possible Orthologues:

Histone Deacetylase 9

Ensembl ID : ENSCDRG00005005657
Gene Symbol: HDAC9
1 Cross references
233 Possible Orthologues:

Hydroxysteroid 11-Beta Dehydrogenase 1

Ensembl ID : ENSCDRG00005006991
Gene Symbol: HSD11B1
3 Cross references
267 Possible Orthologues:

Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 4

Ensembl ID : ENSCDRG00005007849
Gene Symbol: HCN4
1 Cross references
288 Possible Orthologues:

Hypocretin Receptor 1

Ensembl ID : ENSCDRG00005017596
Gene Symbol: HCRTR1
3 Cross references
95 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).